Navigation Links
Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance
Date:12/11/2008

CARY, N.C., Dec. 11 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq: CRTX), a specialty pharmaceutical company focused on developing and commercializing prescription medications for respiratory disorders, today provided an update on the status of its integration activities following the closing of the business combination of Critical Therapeutics, Inc. and Cornerstone BioPharma Holdings, Inc. on October 31, 2008, and the renaming of the combined company as Cornerstone Therapeutics Inc. (the Company).

Following the October 31, 2008 closing, the Company has been taking action to effectively and efficiently combine the operations of the two companies. In completing the integration, the Company has achieved a number of key milestones:

  • The Company has discontinued all former Critical Therapeutics research projects and completed a review of those research projects to identify promising technologies suitable for outlicensing to third parties. As a result of this review, the Company has initiated a process to seek potential licensees for certain technologies, including the alpha 7 mediated anti-inflammatory pathway program.
  • The Company completed a restructuring of former Critical Therapeutics officers and employees that resulted in Scott Townsend, General Counsel and Executive Vice President of Legal Affairs, and 12 former Critical Therapeutics sales representatives remaining with Cornerstone.
  • The former Critical Therapeutics facility in Lexington, MA has been vacated and the sublease terminated.

Aggregate revenues from the Company's products have continued to be strong in the fourth quarter. The Company anticipates 2008 net revenues to be in excess of $64 million, which will include revenues attributable to ZYFL
'/>"/>

SOURCE Cornerstone Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
3. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
4. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
5. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
6. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
9. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...,, WELLINGTON, Colo., Nov. 5 Th...dog towns in the western U.S. This rare carnivore...y susceptible to plague and often entire populatio...ldlife Service (FWS) has implemented a ferret bree...ve ferrets into their formerly native habitat. Un...
(Date:11/5/2009)...,, RANCHO CORDOVA, Calif., Nov. 5 /PRNewswire-F... a leading supplier of innovative products for pro...ed results for the first quarter of fiscal 2010. ,... Company reported revenues of $5.2 million, a 15 p...he first quarter a year ago. The Company said the ...
(Date:11/5/2009)...,, LYNBROOK, N.Y., Nov. 5 /PRNewswire-FirstCall...C ), a biopharmaceutical company developing first-...ed its financial results for the third quarter end...appy that, in September of this year, the FDA,s Ar..., by a vote of 12-0, the approval of XIAFLEX(TM) f...
(Date:11/5/2009)...,, SAN DIEGO, CA, November 5, 2009 /PRNewswire-...mpany focused on using proprietary taste receptor-...ients for the food, beverage, and ingredient suppl...d reported financial results for the third quarter...lion for the third quarter of 2009, compared to $4...
Breaking Biology Technology:Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14
...ight Scientists Will Present at First Joint U.S. N...ting on March 11-12, 2008, MOUNTAIN VIEW, Calif.,... leading provider of software, strategic,consultin... drug,development, today announced its broad-based...rican Conference on Pharmacometrics (ACoP). Pharsi...
... MONICA, Calif. and LAS VEGAS, March 4 ,Cord Blood...ilical cord,blood stem cell preservation company (...inging the life saving potential of stem cells to ...ounced its wholly owned,subsidiary, RainMakers Int... on car #49 at the Sunday, March 2, NASCAR UAW-Dod...
...o research teams led by Dr. Michael Verkhovsky and...logy of the University of Helsinki have for the fi... by Complex I in real time. In the future, this wo...ause most of the maternally inherited so-called mi...Complex I. , This achievement required developing...
Other Biology Technology:Pharsight Makes Strong Contribution to Inaugural American Conference on Pharmacometrics 2Pharsight Makes Strong Contribution to Inaugural American Conference on Pharmacometrics 3Cord Blood America Subsidiary Featured at NASCAR Sprint Cup Series Race 2Cord Blood America Subsidiary Featured at NASCAR Sprint Cup Series Race 3Biological electron transfer captured in real time 2
(Date:11/4/2009)...wswire/ -- Global Rainmakers, Inc., an intellectua...boratory, today announced that the company has exi... commercialize its suite of technologies designed ...ngs. ,, During the past four years, the company...and deploy a series of core--but expandable--techn...
(Date:11/3/2009)...009 -- The world,s greatest wines are the result ...input, and something called the "terroir" -- a ter...imate. , Experts will discuss terroir with an ...ay, Nov. 4 in Pittsburgh. "Terroir: Winegrapes an...at the 2009 Annual Meetings of the American Societ...
(Date:11/3/2009)...beling of fruit and vegetables is a new, patented ...ser beam is used to label, or "etch" information o... sticker-type labels. The technology has been lice... and is being used in New Zealand, Australia, and ...n Asia, South Africa, Central and South America, C...
Breaking Biology News(10 mins):Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3Great wines come from great soils 2Laser etching safe alternative for labeling grapefruit 2Show and prove 48926 1NIH funds 249 5 million for research on HIV and the human innate immune system 8837 1NIH funds 249 5 million for research on HIV and the human innate immune system 8837 2NIH funds 249 5 million for research on HIV and the human innate immune system 8837 3NIH funds 249 5 million for research on HIV and the human innate immune system 8837 4Help Us Raise 241 500 in 5 Days to Improve the Health of Shelter Cats 21 48921 1
...A study has found that elementary schools can sign...table consumption among low-income students by pro...ished in the December issue of the international p... that the frequency of students, fruit and vegetab...to 4.09 times daily after a salad bar was introd...
...ARK, MD -- Many fruit farmers in the United States...to realize profits and create repeat business. Pic...ment, and consumer satisfaction with the experienc...l revenues. , A team of researchers from the Univ... U.S. Department of Agriculture compared three dif...
... Virginia (Dec. 6, 2007) Scientists exploring one...t in Western Africa discovered significant populat...ing the areas high biological diversity and value....s Atewa Range Forest Reserve (Atewa) led by Conser...P) are presented in a report made public today. , ...
Other Biology News:Kids eat more fruits, vegetables when schools offer salad bar 2Strawberry fields ripe for the picking 2New, rare and threatened species discovered in Ghana 2New, rare and threatened species discovered in Ghana 3
Mouse Anti-Bovine GTP BINDING PROTEIN Monoclonal Antibody, Unconjugated, Clone 1H6 from AbD Serotec
... E. coli containing a clone of the human Topoisome...ters the topological state of nucleic acids by pas... which generates a separate DNA helix (1,2) . As a...sm, the enzyme can relax negatively or positively ...
...ral Stem Cell Expansion Kit - Monolayer is a syste...ayer in a serum-free environment. The kit contains... which has been optimized for neural stem cell exp...ment 10 :3129). Human fibroblast growth factor ba...
AMV Reverse Transcriptase from Promega
Biology Products: